Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience

OBJECTIVES: Biomarkers for invasive fungal disease (IFD) have been shown to reduce antifungal prescriptions in neutropaenic haemato-oncology patients. Our study aimed to assess the real-life impacts of introducing a novel biomarker-based pathway, incorporating serum galactomannan and Aspergillus PCR...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Med Microbiol
Main Authors: Martinelli, Anthony W., Wright, Callum B., Lopes, Marta S., Swayne, Rosemary L., Krishnamurthy, Pramila, Crawley, Charles, Uttenthal, Ben, Follows, George, Babar, Judith, Aliyu, Sani H., Enoch, David A., Sander, Clare R.
Formato: Artigo
Idioma:Inglês
Publicado: 2022
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613179/
https://ncbi.nlm.nih.gov/pubmed/35819894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/jmm.0.001564
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares